CN Stock MarketDetailed Quotes

Shanghai Pharmaceuticals Holding (601607)

Watchlist
  • 16.89
  • -0.16-0.94%
Not Open May 14 15:00 CST
62.63BMarket Cap10.78P/E (TTM)

Shanghai Pharmaceuticals Holding (601607) Income Statement

All
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q9)Sep 30, 2025
(Q6)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
Total operating revenue
6.36%75.26B
3.03%283.58B
2.60%215.07B
1.56%141.59B
0.87%70.76B
5.75%275.25B
6.14%209.63B
5.14%139.41B
5.93%70.15B
12.21%260.3B
Operating revenue
6.36%75.26B
3.03%283.58B
2.60%215.07B
1.56%141.59B
0.87%70.76B
5.75%275.25B
6.14%209.63B
5.14%139.41B
5.93%70.15B
12.21%260.3B
Other operating revenue
----
-3.50%1.03B
----
13.15%481.15M
----
-6.88%1.06B
----
-13.29%425.22M
----
54.20%1.14B
Total operating cost
6.06%72.83B
3.22%276.28B
2.94%209.41B
2.02%137.61B
1.14%68.67B
5.80%267.68B
6.30%203.43B
5.21%134.89B
6.03%67.89B
12.49%253.01B
Operating cost
5.77%67.17B
3.49%253.16B
3.33%192.65B
2.77%126.66B
2.22%63.51B
6.84%244.62B
7.44%186.45B
6.67%123.25B
7.87%62.12B
13.63%228.97B
Operating tax surcharges
18.91%241.44M
9.81%854.16M
6.89%635.97M
4.00%415.65M
-2.64%203.04M
5.39%777.88M
8.50%594.97M
5.97%399.68M
8.20%208.54M
3.05%738.11M
Operating expense
18.61%3.27B
3.87%13.21B
-1.70%9.32B
-6.09%6.16B
-16.11%2.76B
-8.55%12.71B
-9.46%9.48B
-15.10%6.57B
-15.86%3.29B
-2.64%13.9B
Administration expense
-0.65%1.32B
-6.63%5.31B
0.65%4.17B
-7.21%2.66B
-4.81%1.32B
-0.38%5.69B
-1.22%4.14B
3.86%2.87B
0.90%1.39B
14.43%5.71B
Financial expense
-4.78%356.82M
-4.98%1.41B
-2.99%1.11B
6.21%749.77M
0.08%374.72M
-0.33%1.48B
-0.45%1.15B
-8.70%705.94M
-10.46%374.43M
13.14%1.49B
-Interest expense (Financial expense)
-21.72%347.64M
-9.20%1.69B
-7.65%1.28B
-3.28%887.69M
-5.85%444.08M
-1.50%1.86B
-5.10%1.39B
-4.64%917.77M
-4.13%471.67M
11.59%1.88B
-Interest Income (Financial expense)
53.65%-38.7M
22.48%-404.97M
25.62%-270.23M
31.31%-176.38M
38.73%-83.49M
-13.11%-522.39M
-1.84%-363.3M
-20.80%-256.78M
-25.24%-136.28M
-5.37%-461.83M
Research and development
-5.79%468.22M
-2.27%2.34B
-6.23%1.52B
-13.22%958.95M
-0.88%497.02M
8.64%2.39B
10.09%1.62B
7.67%1.11B
-7.26%501.45M
4.35%2.2B
Credit Impairment Loss
-7.47%-274.44M
-154.11%-574.71M
-44.56%-624.8M
-44.57%-423.97M
5.07%-255.37M
19.22%-226.16M
-45.77%-432.22M
12.80%-293.26M
-300.73%-269.02M
10.40%-279.96M
Asset Impairment Loss
-314.84%-72.02M
-65.79%-1.02B
-1,119.12%-789.41M
-1,022.70%-410.08M
23.13%33.52M
-9.46%-614.37M
-290.94%-64.75M
-155.26%-36.53M
126.50%27.22M
-69.33%-561.28M
Other net revenue
-141.77%-21.1M
367.41%2.65B
464.11%2.67B
826.45%2.85B
-67.15%50.51M
48.57%566.08M
10.75%473.4M
79.30%307.92M
-48.37%153.76M
-80.37%381.01M
Fair value change income
62.44%61.41M
62.92%332.12M
-20.44%113.14M
-33.72%75.75M
-27.65%37.8M
-49.63%203.85M
-40.51%142.2M
-41.94%114.29M
-41.55%52.25M
85.03%404.73M
Invest income
-108.22%-14.12M
733.31%3.17B
881.11%3.37B
1,222.17%3.26B
3.18%171.74M
658.44%380.43M
509.78%343.49M
223.81%246.36M
7.27%166.44M
-112.78%-68.12M
-Including: Investment income associates
-87.49%27M
-45.49%284.47M
7.10%479.62M
4.12%380.66M
6.17%215.83M
303.55%521.91M
398.03%447.83M
658.88%365.61M
0.79%203.28M
-75.45%129.33M
Asset deal income
18,791.20%168.79M
-16.39%157.15M
9.78%160.09M
-71.30%39.99M
-100.82%-903.05K
103.26%187.97M
39.44%145.83M
88.91%139.31M
405.21%110.04M
-93.57%92.48M
Other revenue
71.50%109.28M
-8.60%579.81M
30.28%441.45M
127.74%313.7M
-4.65%63.72M
-20.02%634.37M
-21.25%338.85M
-62.81%137.74M
-66.80%66.83M
101.43%793.16M
Operating profit
12.49%2.41B
22.13%9.94B
25.01%8.34B
41.46%6.83B
-11.11%2.15B
6.18%8.14B
1.72%6.67B
5.99%4.83B
-3.05%2.41B
-14.95%7.67B
Add:Non operating Income
18.29%22.17M
-32.45%105.65M
115.09%73.32M
44.98%21.84M
29.26%18.74M
284.37%156.4M
23.92%34.09M
-16.81%15.06M
3.94%14.5M
24.14%40.69M
Less:Non operating expense
40.50%17.44M
-17.75%227.93M
91.52%111.99M
44.69%34.64M
-0.53%12.41M
-57.60%277.11M
-9.29%58.48M
-43.54%23.94M
-1.31%12.48M
173.40%653.63M
Total profit
12.38%2.42B
22.44%9.82B
24.89%8.3B
41.45%6.82B
-10.92%2.15B
13.69%8.02B
1.92%6.64B
6.36%4.82B
-3.02%2.42B
-19.91%7.05B
Less:Income tax cost
11.04%569.09M
32.38%2.85B
42.62%2.31B
49.11%1.83B
-7.00%512.52M
13.89%2.15B
3.57%1.62B
9.66%1.22B
2.28%551.13M
3.93%1.89B
Net profit
12.80%1.85B
18.80%6.97B
19.17%5.99B
38.85%4.99B
-12.08%1.64B
13.62%5.87B
1.40%5.02B
5.28%3.6B
-4.48%1.87B
-26.11%5.17B
Net profit from continuing operation
12.80%1.85B
18.80%6.97B
19.17%5.99B
38.85%4.99B
-12.08%1.64B
13.62%5.87B
1.40%5.02B
5.28%3.6B
-4.48%1.87B
-26.11%5.17B
Less:Minority Profit
40.77%432.35M
-5.19%1.25B
-13.42%839.08M
-18.24%535.92M
-5.00%307.12M
-5.80%1.32B
-16.24%969.12M
-18.80%655.45M
-25.75%323.29M
1.72%1.4B
Net profit of parent company owners
6.35%1.42B
25.74%5.72B
26.96%5.15B
51.56%4.46B
-13.56%1.33B
20.82%4.55B
6.78%4.05B
12.72%2.94B
1.62%1.54B
-32.92%3.77B
Earning per share
Basic earning per share
5.56%0.38
25.20%1.54
27.52%1.39
51.90%1.2
-14.29%0.36
20.59%1.23
5.83%1.09
11.27%0.79
2.44%0.42
-36.65%1.02
Diluted earning per share
5.56%0.38
25.20%1.54
27.52%1.39
51.90%1.2
-14.29%0.36
20.59%1.23
5.83%1.09
11.27%0.79
2.44%0.42
-36.65%1.02
Other composite income
-387.46%-16.78M
112.14%7.6M
153.30%14.17M
155.21%19.68M
-842.99%-3.44M
50.59%-62.62M
84.45%-26.59M
70.99%-35.64M
101.48%463.24K
44.05%-126.72M
Other composite income of parent company owners
-205.16%-18.86M
103.43%1.31M
91.30%-3.03M
112.84%4.16M
-25.78%-6.18M
69.39%-38.19M
79.19%-34.85M
74.46%-32.41M
83.92%-4.91M
45.02%-124.77M
Other composite income of minority owners
-24.03%2.08M
125.76%6.29M
108.20%17.2M
580.25%15.52M
-49.08%2.74M
-1,150.05%-24.43M
334.02%8.26M
-179.44%-3.23M
774.36%5.38M
-535.08%-1.95M
Total composite income
12.01%1.83B
20.21%6.98B
20.09%6B
40.79%5.01B
-12.29%1.64B
15.23%5.81B
4.47%5B
8.12%3.56B
-2.90%1.87B
-25.51%5.04B
Total composite income of parent company owners
5.43%1.4B
26.84%5.73B
27.98%5.14B
53.40%4.46B
-13.69%1.33B
23.91%4.51B
10.75%4.02B
17.18%2.91B
3.38%1.54B
-32.41%3.64B
Total composite income of minority owners
40.20%434.43M
-2.91%1.26B
-12.39%856.29M
-15.45%551.44M
-5.72%309.86M
-7.42%1.29B
-15.27%977.38M
-19.60%652.22M
-24.37%328.67M
1.55%1.4B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Deloitte Touche Tohmatsu Certified Public Accountants (Special General Partnership)
--
--
--
Deloitte Touche Tohmatsu Certified Public Accountants (Special General Partnership)
--
--
--
PwC Zhongtian Certified Public Accountants (Special General Partnership)
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q9)Sep 30, 2025(Q6)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023
Total operating revenue 6.36%75.26B3.03%283.58B2.60%215.07B1.56%141.59B0.87%70.76B5.75%275.25B6.14%209.63B5.14%139.41B5.93%70.15B12.21%260.3B
Operating revenue 6.36%75.26B3.03%283.58B2.60%215.07B1.56%141.59B0.87%70.76B5.75%275.25B6.14%209.63B5.14%139.41B5.93%70.15B12.21%260.3B
Other operating revenue -----3.50%1.03B----13.15%481.15M-----6.88%1.06B-----13.29%425.22M----54.20%1.14B
Total operating cost 6.06%72.83B3.22%276.28B2.94%209.41B2.02%137.61B1.14%68.67B5.80%267.68B6.30%203.43B5.21%134.89B6.03%67.89B12.49%253.01B
Operating cost 5.77%67.17B3.49%253.16B3.33%192.65B2.77%126.66B2.22%63.51B6.84%244.62B7.44%186.45B6.67%123.25B7.87%62.12B13.63%228.97B
Operating tax surcharges 18.91%241.44M9.81%854.16M6.89%635.97M4.00%415.65M-2.64%203.04M5.39%777.88M8.50%594.97M5.97%399.68M8.20%208.54M3.05%738.11M
Operating expense 18.61%3.27B3.87%13.21B-1.70%9.32B-6.09%6.16B-16.11%2.76B-8.55%12.71B-9.46%9.48B-15.10%6.57B-15.86%3.29B-2.64%13.9B
Administration expense -0.65%1.32B-6.63%5.31B0.65%4.17B-7.21%2.66B-4.81%1.32B-0.38%5.69B-1.22%4.14B3.86%2.87B0.90%1.39B14.43%5.71B
Financial expense -4.78%356.82M-4.98%1.41B-2.99%1.11B6.21%749.77M0.08%374.72M-0.33%1.48B-0.45%1.15B-8.70%705.94M-10.46%374.43M13.14%1.49B
-Interest expense (Financial expense) -21.72%347.64M-9.20%1.69B-7.65%1.28B-3.28%887.69M-5.85%444.08M-1.50%1.86B-5.10%1.39B-4.64%917.77M-4.13%471.67M11.59%1.88B
-Interest Income (Financial expense) 53.65%-38.7M22.48%-404.97M25.62%-270.23M31.31%-176.38M38.73%-83.49M-13.11%-522.39M-1.84%-363.3M-20.80%-256.78M-25.24%-136.28M-5.37%-461.83M
Research and development -5.79%468.22M-2.27%2.34B-6.23%1.52B-13.22%958.95M-0.88%497.02M8.64%2.39B10.09%1.62B7.67%1.11B-7.26%501.45M4.35%2.2B
Credit Impairment Loss -7.47%-274.44M-154.11%-574.71M-44.56%-624.8M-44.57%-423.97M5.07%-255.37M19.22%-226.16M-45.77%-432.22M12.80%-293.26M-300.73%-269.02M10.40%-279.96M
Asset Impairment Loss -314.84%-72.02M-65.79%-1.02B-1,119.12%-789.41M-1,022.70%-410.08M23.13%33.52M-9.46%-614.37M-290.94%-64.75M-155.26%-36.53M126.50%27.22M-69.33%-561.28M
Other net revenue -141.77%-21.1M367.41%2.65B464.11%2.67B826.45%2.85B-67.15%50.51M48.57%566.08M10.75%473.4M79.30%307.92M-48.37%153.76M-80.37%381.01M
Fair value change income 62.44%61.41M62.92%332.12M-20.44%113.14M-33.72%75.75M-27.65%37.8M-49.63%203.85M-40.51%142.2M-41.94%114.29M-41.55%52.25M85.03%404.73M
Invest income -108.22%-14.12M733.31%3.17B881.11%3.37B1,222.17%3.26B3.18%171.74M658.44%380.43M509.78%343.49M223.81%246.36M7.27%166.44M-112.78%-68.12M
-Including: Investment income associates -87.49%27M-45.49%284.47M7.10%479.62M4.12%380.66M6.17%215.83M303.55%521.91M398.03%447.83M658.88%365.61M0.79%203.28M-75.45%129.33M
Asset deal income 18,791.20%168.79M-16.39%157.15M9.78%160.09M-71.30%39.99M-100.82%-903.05K103.26%187.97M39.44%145.83M88.91%139.31M405.21%110.04M-93.57%92.48M
Other revenue 71.50%109.28M-8.60%579.81M30.28%441.45M127.74%313.7M-4.65%63.72M-20.02%634.37M-21.25%338.85M-62.81%137.74M-66.80%66.83M101.43%793.16M
Operating profit 12.49%2.41B22.13%9.94B25.01%8.34B41.46%6.83B-11.11%2.15B6.18%8.14B1.72%6.67B5.99%4.83B-3.05%2.41B-14.95%7.67B
Add:Non operating Income 18.29%22.17M-32.45%105.65M115.09%73.32M44.98%21.84M29.26%18.74M284.37%156.4M23.92%34.09M-16.81%15.06M3.94%14.5M24.14%40.69M
Less:Non operating expense 40.50%17.44M-17.75%227.93M91.52%111.99M44.69%34.64M-0.53%12.41M-57.60%277.11M-9.29%58.48M-43.54%23.94M-1.31%12.48M173.40%653.63M
Total profit 12.38%2.42B22.44%9.82B24.89%8.3B41.45%6.82B-10.92%2.15B13.69%8.02B1.92%6.64B6.36%4.82B-3.02%2.42B-19.91%7.05B
Less:Income tax cost 11.04%569.09M32.38%2.85B42.62%2.31B49.11%1.83B-7.00%512.52M13.89%2.15B3.57%1.62B9.66%1.22B2.28%551.13M3.93%1.89B
Net profit 12.80%1.85B18.80%6.97B19.17%5.99B38.85%4.99B-12.08%1.64B13.62%5.87B1.40%5.02B5.28%3.6B-4.48%1.87B-26.11%5.17B
Net profit from continuing operation 12.80%1.85B18.80%6.97B19.17%5.99B38.85%4.99B-12.08%1.64B13.62%5.87B1.40%5.02B5.28%3.6B-4.48%1.87B-26.11%5.17B
Less:Minority Profit 40.77%432.35M-5.19%1.25B-13.42%839.08M-18.24%535.92M-5.00%307.12M-5.80%1.32B-16.24%969.12M-18.80%655.45M-25.75%323.29M1.72%1.4B
Net profit of parent company owners 6.35%1.42B25.74%5.72B26.96%5.15B51.56%4.46B-13.56%1.33B20.82%4.55B6.78%4.05B12.72%2.94B1.62%1.54B-32.92%3.77B
Earning per share
Basic earning per share 5.56%0.3825.20%1.5427.52%1.3951.90%1.2-14.29%0.3620.59%1.235.83%1.0911.27%0.792.44%0.42-36.65%1.02
Diluted earning per share 5.56%0.3825.20%1.5427.52%1.3951.90%1.2-14.29%0.3620.59%1.235.83%1.0911.27%0.792.44%0.42-36.65%1.02
Other composite income -387.46%-16.78M112.14%7.6M153.30%14.17M155.21%19.68M-842.99%-3.44M50.59%-62.62M84.45%-26.59M70.99%-35.64M101.48%463.24K44.05%-126.72M
Other composite income of parent company owners -205.16%-18.86M103.43%1.31M91.30%-3.03M112.84%4.16M-25.78%-6.18M69.39%-38.19M79.19%-34.85M74.46%-32.41M83.92%-4.91M45.02%-124.77M
Other composite income of minority owners -24.03%2.08M125.76%6.29M108.20%17.2M580.25%15.52M-49.08%2.74M-1,150.05%-24.43M334.02%8.26M-179.44%-3.23M774.36%5.38M-535.08%-1.95M
Total composite income 12.01%1.83B20.21%6.98B20.09%6B40.79%5.01B-12.29%1.64B15.23%5.81B4.47%5B8.12%3.56B-2.90%1.87B-25.51%5.04B
Total composite income of parent company owners 5.43%1.4B26.84%5.73B27.98%5.14B53.40%4.46B-13.69%1.33B23.91%4.51B10.75%4.02B17.18%2.91B3.38%1.54B-32.41%3.64B
Total composite income of minority owners 40.20%434.43M-2.91%1.26B-12.39%856.29M-15.45%551.44M-5.72%309.86M-7.42%1.29B-15.27%977.38M-19.60%652.22M-24.37%328.67M1.55%1.4B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --Deloitte Touche Tohmatsu Certified Public Accountants (Special General Partnership)------Deloitte Touche Tohmatsu Certified Public Accountants (Special General Partnership)------PwC Zhongtian Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More